Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial

INTRODUCTION: Tenofovir‐containing oral pre‐exposure prophylaxis (PrEP) is recommended for those at substantial risk as part of combination HIV prevention. However, there are limited data, beyond clinical trial settings, to guide the introduction of PrEP in healthcare services with adequate levels o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansoor, Leila E, Yende‐Zuma, Nonhlanhla, Baxter, Cheryl, Mngadi, Kathryn T, Dawood, Halima, Gengiah, Tanuja N, Samsunder, Natasha, Schwartz, Jill L, Doncel, Gustavo F, Abdool Karim, Quarraisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737288/
https://www.ncbi.nlm.nih.gov/pubmed/31507088
http://dx.doi.org/10.1002/jia2.25381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737288/
https://www.ncbi.nlm.nih.gov/pubmed/31507088
http://dx.doi.org/10.1002/jia2.25381

Ejemplares similares